Design of oral insulin delivery systems
Author:
- 5 October 2009
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 18 (2) , 79-92
Abstract
The possibility of administering insulin orally in replacement of painful subcutaneous route has been investigated over years but with varying degree of success. Nanoparticles, microparticles, hydrogel, capsule, tablet, and film patch are designed to deliver insulin orally. They are largely formulated with polymeric adhesive, protease inhibitor, insulin aggregation inhibitor, and functional excipients to induce transcellular, paracellular, Peyer’s patches, or receptor-mediated transport of insulin in gastrointestinal tract. Superporous matrix, intestinal patches, and charged-coupled micromagnet microparticles are recent formulation strategies to promote oral insulin absorption. The formulation emphasizes on assembly of insulin and excipients into a physical structure which provides an element of drug targeting to maintain stability and increase bioavailability of insulin. The overview of various strategies applied in oral insulin delivery system design denotes the significance of mucoadhesiveness whereby a prolonged retention of dosage form in intestinal tract translates to cumulative insulin release and absorption, overcoming the intestinal transport capacity limit. Synthesis and use of mucoadhesive excipients, chemical modification of insulin to promote its physicochemical and biological stability for encapsulation in dosage form with prolonged retention characteristics and identification of potential insulin adjuncts are efforts needed to accelerate the speed of obtaining a functional oral insulin delivery system.Keywords
This publication has 72 references indexed in Scilit:
- The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromoleculesBiomaterials, 2008
- Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymersInternational Journal of Pharmaceutics, 2007
- Oral delivery of insulin associated to polymeric nanoparticles in diabetic ratsJournal of Controlled Release, 2007
- Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluationJournal of Controlled Release, 2006
- Exhuberance Over ExuberaClinical Diabetes, 2006
- Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugsJournal of Controlled Release, 2005
- Gastrointestinal patch systems for oral drug deliveryDrug Discovery Today, 2005
- Use of natural plant exudates (Sanguis Draxonis) for sustained oral insulin delivery with dramatic reduction of glycemic effects in diabetic ratsJournal of Controlled Release, 2004
- Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus1Abbreviations: s.c., subcutaneous; i.p., intraperitoneal; i.v., intravenous; IFA, incomplete Freund's adjuvant; DTP, diphtheria-tetanus-pertussis; LCMV, lymphocytic choriomeningitis virus; GAD, glutamic acid decarboxylase; ICA, islet cell autoantibody; JDF, juvenile diabetes foundation; IAA, insulin autoantibody; GAA, glutamic acid decarboxylase autoantibody; DM, diabetes mellitus; RIA, radioimmunoassay; AA, autoantibody; kD, kilodalton; FPIR, first phase insulin release; IIF, indirect immunofluoresence; IGT, impaired glucose tolerance; OGT, oral glucose tolerance.1Advanced Drug Delivery Reviews, 1999
- Sulfhydryl Compounds May Mediate Gastric CytoprotectionScience, 1981